HAZELWOOD GROUP PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: M84042 | BIRMINGHAM, B46 3LD
Showing results 551-600 of 683
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fusidic acid | 18 | 115 | £404 | +74.2% ▲ |
| Apraclonidine | 18 | 115 | £238 | +42.9% ▲ |
| Azelastine hydrochloride | 18 | 528 | £232 | +60.6% ▲ |
| Fluocinolone acetonide | 18 | 1,460 | £193 | +65.3% ▲ |
| 18 | 494 | £104 | -39.7% ▼ | |
| 18 | 180 | £15 | +391.9% ▲ | |
| 18 | 230 | £594 | +53.1% ▲ | |
| 18 | 1,930 | £6.6K | +74.9% ▲ | |
| 18 | 1,305 | £2.3K | +105.4% ▲ | |
| Norethisterone | 17 | 2,184 | £51 | +21.6% ▲ |
| Mycophenolate mofetil | 17 | 952 | £109 | -58.0% ▼ |
| Cinacalcet hydrochloride | 17 | 1,708 | £931 | -26.7% ▼ |
| Other selenium preparations | 17 | 449 | £113 | +80.1% ▲ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 17 | 175.0K | £1.1K | -16.0% ▼ |
| Ciclesonide | 16 | 16 | £422 | +8.7% ▲ |
| Ferrous gluconate | 16 | 896 | £26 | -66.5% ▼ |
| Crotamiton | 16 | 570 | £57 | -3.8% ▼ |
| 16 | 2,490 | £4.1K | -24.4% ▼ | |
| 16 | 16 | £153 | +60.0% ▲ | |
| 16 | 6,150 | £258 | -58.0% ▼ | |
| 16 | 480 | £889 | +7.8% ▲ | |
| 16 | 640 | £3.3K | +69.5% ▲ | |
| 16 | 2,040 | £475 | +53.7% ▲ | |
| Propantheline bromide | 15 | 1,316 | £401 | +15.6% ▲ |
| Zinc oxide | 15 | 372 | £46 | -27.5% ▼ |
| Formoterol/glycopyrronium/budesonide | 15 | 15 | £634 | -75.1% ▼ |
| Codeine phosphate | 15 | 4,500 | £109 | +4.5% ▲ |
| Daridorexant | 15 | 450 | £599 | +14.8% ▲ |
| Oxcarbazepine | 15 | 814 | £126 | -46.4% ▼ |
| Sodium feredetate | 15 | 8,000 | £226 | -47.6% ▼ |
| Other phosphate supplement preparations | 15 | 300 | £58 | +145.8% ▲ |
| Calcium acetate | 15 | 1,756 | £139 | -18.9% ▼ |
| RtS 2.4 kcal/ml milkshake lower volume with fibre (0913021) | 15 | 225.0K | £8.4K | +60.0% ▲ |
| Acetylcysteine | 15 | 150 | £1.2K | +48.0% ▲ |
| 15 | 930 | £137 | +46.7% ▲ | |
| 15 | 842 | £228 | -49.0% ▼ | |
| Nizatidine | 14 | 840 | £407 | -59.3% ▼ |
| Minoxidil | 14 | 212 | £51 | +25.6% ▲ |
| Olmesartan medoxomil/hydrochlorothiazide | 14 | 392 | £172 | +41.2% ▲ |
| Desloratadine | 14 | 420 | £35 | -51.5% ▼ |
| Rifaximin | 14 | 756 | £3.5K | -47.9% ▼ |
| Combined ethinylestradiol 35mcg | 14 | 1,617 | £114 | +12.4% ▲ |
| Fesoterodine fumarate | 14 | 392 | £33 | -64.5% ▼ |
| Triptorelin embonate | 14 | 14 | £5.2K | +40.6% ▲ |
| Powder disc or non ACBS lactose free formula (0913352) | 14 | 48.4K | £967 | +79.7% ▲ |
| Epinastine hydrochloride | 14 | 70 | £123 | +226.8% ▲ |
| Hydrocortisone | 14 | 140 | £99 | +439.1% ▲ |
| Cocois | 14 | 1,640 | £246 | +2.0% ▲ |
| Other preparations | 14 | 1,260 | £233 | +44.8% ▲ |
| 14 | 248 | £70 | +2.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.